The primary mission of the Radiotherapy Development Branch is to support various extramural research mechanisms of: (1) radiation interactions with biologic systems, (2) radiation interactions with biologic materials, and (3) the application of radiation for therapeutic purposes.
This branch oversees grants in a wide range of topics including: radiation physics, radiobiology of tumor cells, normal cells and tissues, development of novel therapeutic tools and development of predictive assays and biomarkers of tumor and normal tissue responses. RDB’s grant portfolio is managed by four Program Directors, each very knowledgeable in their area(s) of expertise.
In addition to grants management, RDB is also involved in promoting radiobiology education. RDB brings together experts from a range of fields to foster improved understanding and therapeutic utility of radiation and other forms of energy. RDB is involved with NIAID and the Biomedical Advanced Research and Development Authority (BARDA) on issues of radiologic protection. RDB also, works with other Federal agencies to identify knowledge gaps, research opportunities, and develop proposals for funding through the Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) program.
Eric Bernhard, PhD